» Articles » PMID: 21105029

A Pooled Analysis of 14 Cohort Studies of Anthropometric Factors and Pancreatic Cancer Risk

Abstract

Epidemiologic studies of pancreatic cancer risk have reported null or nonsignificant positive associations for obesity, while associations for height have been null. Waist and hip circumference have been evaluated infrequently. A pooled analysis of 14 cohort studies on 846,340 individuals was conducted; 2,135 individuals were diagnosed with pancreatic cancer during follow-up. Study-specific relative risks (RRs) and 95% confidence intervals (CIs) were calculated by Cox proportional hazards models, and then pooled using a random effects model. Compared to individuals with a body mass index (BMI) at baseline between 21-22.9 kg/m(2) , pancreatic cancer risk was 47% higher (95%CI:23-75%) among obese (BMI ≥ 30 kg/m(2) ) individuals. A positive association was observed for BMI in early adulthood (pooled multivariate [MV]RR = 1.30, 95%CI = 1.09-1.56 comparing BMI ≥ 25 kg/m(2) to a BMI between 21 and 22.9 kg/m(2) ). Compared to individuals who were not overweight in early adulthood (BMI < 25 kg/m(2) ) and not obese at baseline (BMI < 30 kg/m(2) ), pancreatic cancer risk was 54% higher (95%CI = 24-93%) for those who were overweight in early adulthood and obese at baseline. We observed a 40% higher risk among individuals who had gained BMI ≥ 10 kg/m(2) between BMI at baseline and younger ages compared to individuals whose BMI remained stable. Results were either similar or slightly stronger among never smokers. A positive association was observed between waist to hip ratio (WHR) and pancreatic cancer risk (pooled MVRR = 1.35 comparing the highest versus lowest quartile, 95%CI = 1.03-1.78). BMI and WHR were positively associated with pancreatic cancer risk. Maintaining normal body weight may offer a feasible approach to reducing morbidity and mortality from pancreatic cancer.

Citing Articles

Pancreatic endocrine and exocrine signaling and crosstalk in physiological and pathological status.

Hu C, Chen Y, Yin X, Xu R, Yin C, Wang C Signal Transduct Target Ther. 2025; 10(1):39.

PMID: 39948335 PMC: 11825823. DOI: 10.1038/s41392-024-02098-3.


Exploring the potential of gemcitabine-metal-organic frameworks in combating pancreatic cancer under ketogenic conditions.

Nekoufar S, Ghorbani M, Safaei S, Khosroushahi G, Shirian F, Baradaran B BMC Cancer. 2025; 25(1):53.

PMID: 39789481 PMC: 11720622. DOI: 10.1186/s12885-024-13397-x.


Waist circumference-years and cancer risk: a prospective study of the association and comparison of predictive performance with waist circumference and body mass index.

Hawwash N, Sperrin M, Martin G, Joshu C, Florido R, Platz E Br J Cancer. 2024; 131(10):1623-1634.

PMID: 39367274 PMC: 11554801. DOI: 10.1038/s41416-024-02860-y.


Pancreatic cancer mortality trends in the United States: how much have we moved the needle?.

Tan J, Yeo Y, Ng W, Chiang C, Stucky C, Wasif N J Gastrointest Oncol. 2024; 15(4):1789-1795.

PMID: 39279936 PMC: 11399823. DOI: 10.21037/jgo-24-213.


G-quadruplex forming regions in GCK and TM6SF2 are targets for differential DNA methylation in metabolic disease and hepatocellular carcinoma patients.

Lahnsteiner A, Ellmer V, Oberlercher A, Liutkeviciute Z, Schonauer E, Paulweber B Sci Rep. 2024; 14(1):20215.

PMID: 39215018 PMC: 11364803. DOI: 10.1038/s41598-024-70749-0.


References
1.
Calton B, Stolzenberg-Solomon R, Moore S, Schatzkin A, Schairer C, Albanes D . A prospective study of physical activity and the risk of pancreatic cancer among women (United States). BMC Cancer. 2008; 8:63. PMC: 2277426. DOI: 10.1186/1471-2407-8-63. View

2.
Genkinger J, Spiegelman D, Anderson K, Bergkvist L, Bernstein L, van den Brandt P . Alcohol intake and pancreatic cancer risk: a pooled analysis of fourteen cohort studies. Cancer Epidemiol Biomarkers Prev. 2009; 18(3):765-76. PMC: 2715951. DOI: 10.1158/1055-9965.EPI-08-0880. View

3.
Ansary-Moghaddam A, Huxley R, Barzi F, Lawes C, Ohkubo T, Fang X . The effect of modifiable risk factors on pancreatic cancer mortality in populations of the Asia-Pacific region. Cancer Epidemiol Biomarkers Prev. 2006; 15(12):2435-40. DOI: 10.1158/1055-9965.EPI-06-0368. View

4.
Li D, Morris J, Liu J, Hassan M, Day R, Bondy M . Body mass index and risk, age of onset, and survival in patients with pancreatic cancer. JAMA. 2009; 301(24):2553-62. PMC: 2760963. DOI: 10.1001/jama.2009.886. View

5.
Lee I, Sesso H, Oguma Y, Paffenbarger Jr R . Physical activity, body weight, and pancreatic cancer mortality. Br J Cancer. 2003; 88(5):679-83. PMC: 2376353. DOI: 10.1038/sj.bjc.6600782. View